tirzepatide weight loss study New result 🚨 vs semaglutide SURMOUNT 5 RCT 📉Total body loss: −20.2% with tirzepatide −13.7% with semaglutide 🤢Discontinuations due to gastrointestinal events:… Largest real-world study finds tirzepatide

What If I Have Tried GLP-1 Medications Before and Did Not See Results Individual response to any medication varies based on starting weight, metabolic health, hormone levels, and other factors

It is also contraindicated for those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a rare genetic disorder that increases the risk of thyroid cancer

This matters because injection volume changes with concentration

Patients with pre-existing inflammatory bowel disease (IBD), including ulcerative colitis or Crohn's disease, should discuss their condition with their healthcare provider before starting semaglutide

Another routine test that most labs bundle cheaply

Nausea Nausea is the most common GLP-1 side effect, especially during the first few weeks of treatment